Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2021-2030 of 2922 for cancer

Edit search filters
  1. Metabolite Levels In Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

    Rochester, MN

  2. Ovarian and Uterine Cancer Patients' Cancer Diagnosis and Treatment-Related Characteristics from Medical Records

    Rochester, MN

  3. A Study Of Effect Of Megakaryocytes And Platelets In Breast Cancer

    La Crosse, WI

  4. A Study To Analyze The Association Between Financial And Health Insurance Literacy And Financial Distress In Patients Being Treated For Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Risk Factors for Recurrence in Endometrial Cancer Patients

    Rochester, MN

  6. Management of Locoregional Recurrent Breast Cancer

    Rochester, MN

  7. Specimen Collection From Participants Due For Colorectal Cancer Screening, Surveillance, Or Treatment

    Rochester, MN

  8. Resectable, Borderline Resectable, And Locally Advanced Pancreatic Cancer Biorepository Of Peripheral Blood

    Rochester, MN

  9. Leveraging Methylated DNA Markers (MDMs) In The Detection Of Endometrial Cancer And Cervical Cancer: A Phase II Clinical Study

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Rochester, MN

  10. Long Term Outcomes In Pancreas Cancer Patients

    Rochester, MN

.

Mayo Clinic Footer